Global Pharmaceutical Contract Manufacturing Market Research Report 2025(Status and Outlook)
Description
Report Overview
The pharmaceutical contract manufacturing market refers to the global industry in which pharmaceutical companies outsource the production of their drug products to specialized third-party organizations, often referred to as contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs). This market covers oral solid dosage forms such as tablets and granules, including formulation, granulation, compression, coating, and packaging, as well as parenteral dosage forms like vials, syringes, and ampoules, including sterile drug preparation, aseptic filling, lyophilization, labeling, and quality control. Services are provided to branded pharmaceutical companies, generic drug manufacturers, and biotech firms lacking in-house manufacturing capabilities.
The market offers both clinical-scale and commercial-scale production, ensuring compliance with GMP and regulatory standards while enabling clients to reduce costs, accelerate time-to-market, and leverage technical expertise. This segment is strictly focused on tablets, granules, vials, syringes, and ampoules, excluding other pharmaceutical forms such as topical creams, inhalables, or large biologics beyond parenteral formulations.
The global Pharmaceutical Contract Manufacturing market size was estimated at USD XX million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of XX% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pharmaceutical Contract Manufacturing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pharmaceutical Contract Manufacturing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pharmaceutical Contract Manufacturing market.
Global Pharmaceutical Contract Manufacturing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Lonza Group
Thermo Fisher Scientific
Catalent
WuXi Biologics
Samsung Biologics
Boehringer Ingelheim
Fujifilm Diosynth Biotechnologies
Recipharm
Pfizer CentreOne
Charles River Laboratories
AGC Biologics
Jubilant Life Sciences
Alcami Corporation
Evonik Industries
Piramal Pharma Solutions
MilliporeSigma
AbbVie
Emergent BioSolutions
Rentschler Biopharma
Sterling Pharma Solutions
Aenova
Otsuka Pharmaceutical Factory
Nipro Pharma
Bushu Pharma
CMIC Group
Fuji Pharma
Baxter Pharmaceutical Solutions LLC
Fresenius Kabi
Vetter Pharma
Ajinomoto Bio-Pharma Services
Market Segmentation (by Type)
Primary
Secondary
Tertiary
Vials
Syringes
Ampoules
Market Segmentation (by Application)
Branded Pharmaceuticals
Generic Drugs
Biopharmaceuticals/Biologics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pharmaceutical Contract Manufacturing Market
Overview of the regional outlook of the Pharmaceutical Contract Manufacturing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical Contract Manufacturing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pharmaceutical Contract Manufacturing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The pharmaceutical contract manufacturing market refers to the global industry in which pharmaceutical companies outsource the production of their drug products to specialized third-party organizations, often referred to as contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs). This market covers oral solid dosage forms such as tablets and granules, including formulation, granulation, compression, coating, and packaging, as well as parenteral dosage forms like vials, syringes, and ampoules, including sterile drug preparation, aseptic filling, lyophilization, labeling, and quality control. Services are provided to branded pharmaceutical companies, generic drug manufacturers, and biotech firms lacking in-house manufacturing capabilities.
The market offers both clinical-scale and commercial-scale production, ensuring compliance with GMP and regulatory standards while enabling clients to reduce costs, accelerate time-to-market, and leverage technical expertise. This segment is strictly focused on tablets, granules, vials, syringes, and ampoules, excluding other pharmaceutical forms such as topical creams, inhalables, or large biologics beyond parenteral formulations.
The global Pharmaceutical Contract Manufacturing market size was estimated at USD XX million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of XX% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pharmaceutical Contract Manufacturing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pharmaceutical Contract Manufacturing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pharmaceutical Contract Manufacturing market.
Global Pharmaceutical Contract Manufacturing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Lonza Group
Thermo Fisher Scientific
Catalent
WuXi Biologics
Samsung Biologics
Boehringer Ingelheim
Fujifilm Diosynth Biotechnologies
Recipharm
Pfizer CentreOne
Charles River Laboratories
AGC Biologics
Jubilant Life Sciences
Alcami Corporation
Evonik Industries
Piramal Pharma Solutions
MilliporeSigma
AbbVie
Emergent BioSolutions
Rentschler Biopharma
Sterling Pharma Solutions
Aenova
Otsuka Pharmaceutical Factory
Nipro Pharma
Bushu Pharma
CMIC Group
Fuji Pharma
Baxter Pharmaceutical Solutions LLC
Fresenius Kabi
Vetter Pharma
Ajinomoto Bio-Pharma Services
Market Segmentation (by Type)
Primary
Secondary
Tertiary
Vials
Syringes
Ampoules
Market Segmentation (by Application)
Branded Pharmaceuticals
Generic Drugs
Biopharmaceuticals/Biologics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pharmaceutical Contract Manufacturing Market
Overview of the regional outlook of the Pharmaceutical Contract Manufacturing Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical Contract Manufacturing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pharmaceutical Contract Manufacturing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
205 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Pharmaceutical Contract Manufacturing
- 1.2 Key Market Segments
- 1.2.1 Pharmaceutical Contract Manufacturing Segment by Type
- 1.2.2 Pharmaceutical Contract Manufacturing Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Pharmaceutical Contract Manufacturing Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Pharmaceutical Contract Manufacturing Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Pharmaceutical Contract Manufacturing Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Pharmaceutical Contract Manufacturing Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Pharmaceutical Contract Manufacturing Product Life Cycle
- 3.3 Global Pharmaceutical Contract Manufacturing Sales by Manufacturers (2020-2025)
- 3.4 Global Pharmaceutical Contract Manufacturing Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Pharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Pharmaceutical Contract Manufacturing Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Pharmaceutical Contract Manufacturing Market Competitive Situation and Trends
- 3.8.1 Pharmaceutical Contract Manufacturing Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Pharmaceutical Contract Manufacturing Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Pharmaceutical Contract Manufacturing Industry Chain Analysis
- 4.1 Pharmaceutical Contract Manufacturing Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Pharmaceutical Contract Manufacturing Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Pharmaceutical Contract Manufacturing Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Pharmaceutical Contract Manufacturing Market
- 5.7 ESG Ratings of Leading Companies
- 6 Pharmaceutical Contract Manufacturing Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Pharmaceutical Contract Manufacturing Sales Market Share by Type (2020-2025)
- 6.3 Global Pharmaceutical Contract Manufacturing Market Size Market Share by Type (2020-2025)
- 6.4 Global Pharmaceutical Contract Manufacturing Price by Type (2020-2025)
- 7 Pharmaceutical Contract Manufacturing Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Pharmaceutical Contract Manufacturing Market Sales by Application (2020-2025)
- 7.3 Global Pharmaceutical Contract Manufacturing Market Size (M USD) by Application (2020-2025)
- 7.4 Global Pharmaceutical Contract Manufacturing Sales Growth Rate by Application (2020-2025)
- 8 Pharmaceutical Contract Manufacturing Market Sales by Region
- 8.1 Global Pharmaceutical Contract Manufacturing Sales by Region
- 8.1.1 Global Pharmaceutical Contract Manufacturing Sales by Region
- 8.1.2 Global Pharmaceutical Contract Manufacturing Sales Market Share by Region
- 8.2 Global Pharmaceutical Contract Manufacturing Market Size by Region
- 8.2.1 Global Pharmaceutical Contract Manufacturing Market Size by Region
- 8.2.2 Global Pharmaceutical Contract Manufacturing Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Pharmaceutical Contract Manufacturing Sales by Country
- 8.3.2 North America Pharmaceutical Contract Manufacturing Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Pharmaceutical Contract Manufacturing Sales by Country
- 8.4.2 Europe Pharmaceutical Contract Manufacturing Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Pharmaceutical Contract Manufacturing Sales by Region
- 8.5.2 Asia Pacific Pharmaceutical Contract Manufacturing Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Pharmaceutical Contract Manufacturing Sales by Country
- 8.6.2 South America Pharmaceutical Contract Manufacturing Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Pharmaceutical Contract Manufacturing Sales by Region
- 8.7.2 Middle East and Africa Pharmaceutical Contract Manufacturing Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Pharmaceutical Contract Manufacturing Market Production by Region
- 9.1 Global Production of Pharmaceutical Contract Manufacturing by Region(2020-2025)
- 9.2 Global Pharmaceutical Contract Manufacturing Revenue Market Share by Region (2020-2025)
- 9.3 Global Pharmaceutical Contract Manufacturing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Pharmaceutical Contract Manufacturing Production
- 9.4.1 North America Pharmaceutical Contract Manufacturing Production Growth Rate (2020-2025)
- 9.4.2 North America Pharmaceutical Contract Manufacturing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Pharmaceutical Contract Manufacturing Production
- 9.5.1 Europe Pharmaceutical Contract Manufacturing Production Growth Rate (2020-2025)
- 9.5.2 Europe Pharmaceutical Contract Manufacturing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Pharmaceutical Contract Manufacturing Production (2020-2025)
- 9.6.1 Japan Pharmaceutical Contract Manufacturing Production Growth Rate (2020-2025)
- 9.6.2 Japan Pharmaceutical Contract Manufacturing Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Pharmaceutical Contract Manufacturing Production (2020-2025)
- 9.7.1 China Pharmaceutical Contract Manufacturing Production Growth Rate (2020-2025)
- 9.7.2 China Pharmaceutical Contract Manufacturing Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Lonza Group
- 10.1.1 Lonza Group Basic Information
- 10.1.2 Lonza Group Pharmaceutical Contract Manufacturing Product Overview
- 10.1.3 Lonza Group Pharmaceutical Contract Manufacturing Product Market Performance
- 10.1.4 Lonza Group Business Overview
- 10.1.5 Lonza Group SWOT Analysis
- 10.1.6 Lonza Group Recent Developments
- 10.2 Thermo Fisher Scientific
- 10.2.1 Thermo Fisher Scientific Basic Information
- 10.2.2 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing Product Overview
- 10.2.3 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing Product Market Performance
- 10.2.4 Thermo Fisher Scientific Business Overview
- 10.2.5 Thermo Fisher Scientific SWOT Analysis
- 10.2.6 Thermo Fisher Scientific Recent Developments
- 10.3 Catalent
- 10.3.1 Catalent Basic Information
- 10.3.2 Catalent Pharmaceutical Contract Manufacturing Product Overview
- 10.3.3 Catalent Pharmaceutical Contract Manufacturing Product Market Performance
- 10.3.4 Catalent Business Overview
- 10.3.5 Catalent SWOT Analysis
- 10.3.6 Catalent Recent Developments
- 10.4 WuXi Biologics
- 10.4.1 WuXi Biologics Basic Information
- 10.4.2 WuXi Biologics Pharmaceutical Contract Manufacturing Product Overview
- 10.4.3 WuXi Biologics Pharmaceutical Contract Manufacturing Product Market Performance
- 10.4.4 WuXi Biologics Business Overview
- 10.4.5 WuXi Biologics Recent Developments
- 10.5 Samsung Biologics
- 10.5.1 Samsung Biologics Basic Information
- 10.5.2 Samsung Biologics Pharmaceutical Contract Manufacturing Product Overview
- 10.5.3 Samsung Biologics Pharmaceutical Contract Manufacturing Product Market Performance
- 10.5.4 Samsung Biologics Business Overview
- 10.5.5 Samsung Biologics Recent Developments
- 10.6 Boehringer Ingelheim
- 10.6.1 Boehringer Ingelheim Basic Information
- 10.6.2 Boehringer Ingelheim Pharmaceutical Contract Manufacturing Product Overview
- 10.6.3 Boehringer Ingelheim Pharmaceutical Contract Manufacturing Product Market Performance
- 10.6.4 Boehringer Ingelheim Business Overview
- 10.6.5 Boehringer Ingelheim Recent Developments
- 10.7 Fujifilm Diosynth Biotechnologies
- 10.7.1 Fujifilm Diosynth Biotechnologies Basic Information
- 10.7.2 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Manufacturing Product Overview
- 10.7.3 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Manufacturing Product Market Performance
- 10.7.4 Fujifilm Diosynth Biotechnologies Business Overview
- 10.7.5 Fujifilm Diosynth Biotechnologies Recent Developments
- 10.8 Recipharm
- 10.8.1 Recipharm Basic Information
- 10.8.2 Recipharm Pharmaceutical Contract Manufacturing Product Overview
- 10.8.3 Recipharm Pharmaceutical Contract Manufacturing Product Market Performance
- 10.8.4 Recipharm Business Overview
- 10.8.5 Recipharm Recent Developments
- 10.9 Pfizer CentreOne
- 10.9.1 Pfizer CentreOne Basic Information
- 10.9.2 Pfizer CentreOne Pharmaceutical Contract Manufacturing Product Overview
- 10.9.3 Pfizer CentreOne Pharmaceutical Contract Manufacturing Product Market Performance
- 10.9.4 Pfizer CentreOne Business Overview
- 10.9.5 Pfizer CentreOne Recent Developments
- 10.10 Charles River Laboratories
- 10.10.1 Charles River Laboratories Basic Information
- 10.10.2 Charles River Laboratories Pharmaceutical Contract Manufacturing Product Overview
- 10.10.3 Charles River Laboratories Pharmaceutical Contract Manufacturing Product Market Performance
- 10.10.4 Charles River Laboratories Business Overview
- 10.10.5 Charles River Laboratories Recent Developments
- 10.11 AGC Biologics
- 10.11.1 AGC Biologics Basic Information
- 10.11.2 AGC Biologics Pharmaceutical Contract Manufacturing Product Overview
- 10.11.3 AGC Biologics Pharmaceutical Contract Manufacturing Product Market Performance
- 10.11.4 AGC Biologics Business Overview
- 10.11.5 AGC Biologics Recent Developments
- 10.12 Jubilant Life Sciences
- 10.12.1 Jubilant Life Sciences Basic Information
- 10.12.2 Jubilant Life Sciences Pharmaceutical Contract Manufacturing Product Overview
- 10.12.3 Jubilant Life Sciences Pharmaceutical Contract Manufacturing Product Market Performance
- 10.12.4 Jubilant Life Sciences Business Overview
- 10.12.5 Jubilant Life Sciences Recent Developments
- 10.13 Alcami Corporation
- 10.13.1 Alcami Corporation Basic Information
- 10.13.2 Alcami Corporation Pharmaceutical Contract Manufacturing Product Overview
- 10.13.3 Alcami Corporation Pharmaceutical Contract Manufacturing Product Market Performance
- 10.13.4 Alcami Corporation Business Overview
- 10.13.5 Alcami Corporation Recent Developments
- 10.14 Evonik Industries
- 10.14.1 Evonik Industries Basic Information
- 10.14.2 Evonik Industries Pharmaceutical Contract Manufacturing Product Overview
- 10.14.3 Evonik Industries Pharmaceutical Contract Manufacturing Product Market Performance
- 10.14.4 Evonik Industries Business Overview
- 10.14.5 Evonik Industries Recent Developments
- 10.15 Piramal Pharma Solutions
- 10.15.1 Piramal Pharma Solutions Basic Information
- 10.15.2 Piramal Pharma Solutions Pharmaceutical Contract Manufacturing Product Overview
- 10.15.3 Piramal Pharma Solutions Pharmaceutical Contract Manufacturing Product Market Performance
- 10.15.4 Piramal Pharma Solutions Business Overview
- 10.15.5 Piramal Pharma Solutions Recent Developments
- 10.16 MilliporeSigma
- 10.16.1 MilliporeSigma Basic Information
- 10.16.2 MilliporeSigma Pharmaceutical Contract Manufacturing Product Overview
- 10.16.3 MilliporeSigma Pharmaceutical Contract Manufacturing Product Market Performance
- 10.16.4 MilliporeSigma Business Overview
- 10.16.5 MilliporeSigma Recent Developments
- 10.17 AbbVie
- 10.17.1 AbbVie Basic Information
- 10.17.2 AbbVie Pharmaceutical Contract Manufacturing Product Overview
- 10.17.3 AbbVie Pharmaceutical Contract Manufacturing Product Market Performance
- 10.17.4 AbbVie Business Overview
- 10.17.5 AbbVie Recent Developments
- 10.18 Emergent BioSolutions
- 10.18.1 Emergent BioSolutions Basic Information
- 10.18.2 Emergent BioSolutions Pharmaceutical Contract Manufacturing Product Overview
- 10.18.3 Emergent BioSolutions Pharmaceutical Contract Manufacturing Product Market Performance
- 10.18.4 Emergent BioSolutions Business Overview
- 10.18.5 Emergent BioSolutions Recent Developments
- 10.19 Rentschler Biopharma
- 10.19.1 Rentschler Biopharma Basic Information
- 10.19.2 Rentschler Biopharma Pharmaceutical Contract Manufacturing Product Overview
- 10.19.3 Rentschler Biopharma Pharmaceutical Contract Manufacturing Product Market Performance
- 10.19.4 Rentschler Biopharma Business Overview
- 10.19.5 Rentschler Biopharma Recent Developments
- 10.20 Sterling Pharma Solutions
- 10.20.1 Sterling Pharma Solutions Basic Information
- 10.20.2 Sterling Pharma Solutions Pharmaceutical Contract Manufacturing Product Overview
- 10.20.3 Sterling Pharma Solutions Pharmaceutical Contract Manufacturing Product Market Performance
- 10.20.4 Sterling Pharma Solutions Business Overview
- 10.20.5 Sterling Pharma Solutions Recent Developments
- 10.21 Aenova
- 10.21.1 Aenova Basic Information
- 10.21.2 Aenova Pharmaceutical Contract Manufacturing Product Overview
- 10.21.3 Aenova Pharmaceutical Contract Manufacturing Product Market Performance
- 10.21.4 Aenova Business Overview
- 10.21.5 Aenova Recent Developments
- 10.22 Otsuka Pharmaceutical Factory
- 10.22.1 Otsuka Pharmaceutical Factory Basic Information
- 10.22.2 Otsuka Pharmaceutical Factory Pharmaceutical Contract Manufacturing Product Overview
- 10.22.3 Otsuka Pharmaceutical Factory Pharmaceutical Contract Manufacturing Product Market Performance
- 10.22.4 Otsuka Pharmaceutical Factory Business Overview
- 10.22.5 Otsuka Pharmaceutical Factory Recent Developments
- 10.23 Nipro Pharma
- 10.23.1 Nipro Pharma Basic Information
- 10.23.2 Nipro Pharma Pharmaceutical Contract Manufacturing Product Overview
- 10.23.3 Nipro Pharma Pharmaceutical Contract Manufacturing Product Market Performance
- 10.23.4 Nipro Pharma Business Overview
- 10.23.5 Nipro Pharma Recent Developments
- 10.24 Bushu Pharma
- 10.24.1 Bushu Pharma Basic Information
- 10.24.2 Bushu Pharma Pharmaceutical Contract Manufacturing Product Overview
- 10.24.3 Bushu Pharma Pharmaceutical Contract Manufacturing Product Market Performance
- 10.24.4 Bushu Pharma Business Overview
- 10.24.5 Bushu Pharma Recent Developments
- 10.25 CMIC Group
- 10.25.1 CMIC Group Basic Information
- 10.25.2 CMIC Group Pharmaceutical Contract Manufacturing Product Overview
- 10.25.3 CMIC Group Pharmaceutical Contract Manufacturing Product Market Performance
- 10.25.4 CMIC Group Business Overview
- 10.25.5 CMIC Group Recent Developments
- 10.26 Fuji Pharma
- 10.26.1 Fuji Pharma Basic Information
- 10.26.2 Fuji Pharma Pharmaceutical Contract Manufacturing Product Overview
- 10.26.3 Fuji Pharma Pharmaceutical Contract Manufacturing Product Market Performance
- 10.26.4 Fuji Pharma Business Overview
- 10.26.5 Fuji Pharma Recent Developments
- 10.27 Baxter Pharmaceutical Solutions LLC
- 10.27.1 Baxter Pharmaceutical Solutions LLC Basic Information
- 10.27.2 Baxter Pharmaceutical Solutions LLC Pharmaceutical Contract Manufacturing Product Overview
- 10.27.3 Baxter Pharmaceutical Solutions LLC Pharmaceutical Contract Manufacturing Product Market Performance
- 10.27.4 Baxter Pharmaceutical Solutions LLC Business Overview
- 10.27.5 Baxter Pharmaceutical Solutions LLC Recent Developments
- 10.28 Fresenius Kabi
- 10.28.1 Fresenius Kabi Basic Information
- 10.28.2 Fresenius Kabi Pharmaceutical Contract Manufacturing Product Overview
- 10.28.3 Fresenius Kabi Pharmaceutical Contract Manufacturing Product Market Performance
- 10.28.4 Fresenius Kabi Business Overview
- 10.28.5 Fresenius Kabi Recent Developments
- 10.29 Vetter Pharma
- 10.29.1 Vetter Pharma Basic Information
- 10.29.2 Vetter Pharma Pharmaceutical Contract Manufacturing Product Overview
- 10.29.3 Vetter Pharma Pharmaceutical Contract Manufacturing Product Market Performance
- 10.29.4 Vetter Pharma Business Overview
- 10.29.5 Vetter Pharma Recent Developments
- 10.30 Ajinomoto Bio-Pharma Services
- 10.30.1 Ajinomoto Bio-Pharma Services Basic Information
- 10.30.2 Ajinomoto Bio-Pharma Services Pharmaceutical Contract Manufacturing Product Overview
- 10.30.3 Ajinomoto Bio-Pharma Services Pharmaceutical Contract Manufacturing Product Market Performance
- 10.30.4 Ajinomoto Bio-Pharma Services Business Overview
- 10.30.5 Ajinomoto Bio-Pharma Services Recent Developments
- 11 Pharmaceutical Contract Manufacturing Market Forecast by Region
- 11.1 Global Pharmaceutical Contract Manufacturing Market Size Forecast
- 11.2 Global Pharmaceutical Contract Manufacturing Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Pharmaceutical Contract Manufacturing Market Size Forecast by Country
- 11.2.3 Asia Pacific Pharmaceutical Contract Manufacturing Market Size Forecast by Region
- 11.2.4 South America Pharmaceutical Contract Manufacturing Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Pharmaceutical Contract Manufacturing by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Pharmaceutical Contract Manufacturing Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Pharmaceutical Contract Manufacturing by Type (2026-2033)
- 12.1.2 Global Pharmaceutical Contract Manufacturing Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Pharmaceutical Contract Manufacturing by Type (2026-2033)
- 12.2 Global Pharmaceutical Contract Manufacturing Market Forecast by Application (2026-2033)
- 12.2.1 Global Pharmaceutical Contract Manufacturing Sales (K Units) Forecast by Application
- 12.2.2 Global Pharmaceutical Contract Manufacturing Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


